Fexuprazan (trade name Fexuclue) is a drug for the treatment of gastroesophageal reflux disease (GERD). It is a potassium-competitive acid blocker, which is a class of drugs suppressing gastric acids.
Fexuprazan is approved for clinical use in South Korea, Mexico, Philippines, Chile, and Ecuador.